Abstract:Abstract Background Steroid drugs are essential for disease prevention and clinical treatment. However, due to intricated steroid structure, traditional chemical methods are rarely implemented into the whole synthetic process for generating steroid intermediates. Novel steroid drug precursors and their ideal bacterial strains for industrial production have yet to be developed. Among these, 9,21-dihydroxy-20-methyl-pregna-4-en-3-one (9-OH-4-HP) is a novel steroid drug precursor, suitable for the synthesis of corticosteroids. In this study, a combined strategy of blocking Δ 1 -dehydrogenation and the C19 pathway as well as improving the intracellular environment was investigated to construct an effective 9-OH-4-HP-producing strain. Results The Δ 1 -dehydrogenation-deficient strain of wild-type Mycobacterium neoaurum DSM 44074 produces 9-OH-4-HP with a molar yield of 4.8%. Hsd4A , encoding a β-hydroxyacyl-CoA dehydrogenase, and fadA5 , encoding an acyl-CoA thiolase, were separately knocked out to block the C19 pathway in the Δ 1 -dehydrogenation-deficient strain. The two engineered strains were able to accumulate 0.59 g L −1 and 0.47 g L −1 9-OH-4-HP from 1 g L −1 phytosterols, respectively. Furthermore, hsd4A and fadA5 were knocked out simultaneously in the Δ 1 -dehydrogenation-deficient strain. The 9-OH-4-HP production from the Hsd4A and FadA5 deficient strain was 11.9% higher than that of the Hsd4A deficient strain and 40.4% higher than that of the strain with FadA5 deficiency strain, respectively. The purity of 9-OH-4-HP obtained from the Hsd4A and FadA5 deficient strain has reached 94.9%. Subsequently, the catalase katE from Mycobacterium neoaurum and an NADH oxidase, nox , from Bacillus subtilis were overexpressed to improve the intracellular environment, leading to a higher 9-OH-4-HP production. Ultimately, 9-OH-4-HP production reached 3.58 g L −1 from 5 g L −1 phytosterols, and the purity of 9-OH-4-HP improved to 97%. The final 9-OH-4-HP production strain showed the best molar yield of 85.5%, compared with the previous reported strain with 30% molar yield of 9-OH-4-HP. Conclusion KstD, Hsd4A, and FadA5 are key enzymes for phytosterol side-chain degradation in the C19 pathway. Double deletion of hsd4A and fadA5 contributes to the blockage of the C19 pathway. Improving the intracellular environment of Mycobacterium neoaurum during phytosterol bioconversion could accelerate the conversion process and enhance the productivity of target sterol derivatives.

Transformation Condition Optimization of 16Α-Hydroxylation of Prednisolone by Streptomyces Roseochromogenes

Transformation of Prednisolone to a 20Β-Hydroxy Prednisolone Compound by Streptomyces Roseochromogenes TS79

Optimisation of Hydrocortisone Production by Curvularia lunata

Enhanced production of Penicillium expansum PED-03 lipase through control of culture conditions and application of the crude enzyme in kinetic resolution of racemic Allethrolone.

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Optimization of Biotransformation from Phytosterol to Androstenedione by A Mutant Mycobacterium Neoaurum Zjuvn-08

Biotransformation optimization of betulin into betulinic acid production catalysed by cultured Armillaria luteo-virens Sacc ZJUQH100-6 cells.

Enhanced Biocatalytic Production of Cortisol by Protein Engineering and Process Engineering

Metabolic Regulation of Androst-4-ene-3,17-dione 11Α-Hydroxylation Mutant Strain Metarhizium Anisopliae M28-203

Optimization of Culture Conditions for Production of Cis-Epoxysuccinic Acid Hydrolase Using Response Surface Methodology

Fermentation Process Optimization of Novel Immunosuppressant Sanglifehrin A

Functional reconstitution of a steroidal hydroxylase from the fungus Thanatephorus cucumeris in Mycolicibacterium neoaurum for 15α-hydroxylation of progesterone

Optimization of Fermentation Conditions for Trichodermin by the Mutant Strain UL60-11 of Trichoderma Taxi.

Enhanced Single-Step Bioproduction of the Simvastatin Precursor Monacolin J in an Industrial Strain of Aspergillus Terreus by Employing the Evolved Lovastatin Hydrolase

Balancing carbon flux rebalancing around phosphoenolpyruvate node for enhancement of FK506 production in Streptomyces tsukubaensis

Production of 17α-hydroxyprogesterone using an engineered biocatalyst with efficient electron transfer and improved 5-aminolevulinic acid synthesis coupled with a P450 hydroxylase

Optimization of Fermentation Process, Extraction and Separation of Chaetoglobosin A

Extraction Condition Optimizing Of Poly (3-Hydroxybutyric Acid) From Microorganism Using Response Surface Methodology

Elevation of FK506 Production by Regulatory Pathway Engineering and Medium Optimization in Streptomyces Tsukubaensis

Production of 9,21-dihydroxy-20-methyl-pregna-4-en-3-one from phytosterols in Mycobacterium neoaurum by modifying multiple genes and improving the intracellular environment

Kinetic analysis of 11α-hydroxylation of steroids by Rhizopus nigricans